Sei Investments CO Theravance Biopharma, Inc. Transaction History

Sei Investments CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$6.77 - $14.41 $215,367 - $458,410	-31,812 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$14.52 - $22.46 $6,504 - $10,062	-448 Reduced 1.39%	31,812 $462,000
Q1 2021 May 12, 2021	SELL	$16.57 - $21.08 $11,284 - $14,355	-681 Reduced 2.07%	32,260 $658,000
Q4 2020 Feb 08, 2021	BUY	$14.89 - $20.16 $142,750 - $193,273	9,587 Added 41.05%	32,941 $585,000
Q3 2020 Nov 06, 2020	SELL	$14.79 - $22.49 $10,678 - $16,237	-722 Reduced 3.0%	23,354 $345,000

Q2 2020 Aug 17, 2020	BUY	$20.64 - $30.69 $496,928 - $738,892	24,076 New	24,076 $505,000
Q2 2018 Aug 03, 2018	SELL	$22.06 - $25.52 $176 - $204	-8 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$23.88 - $34.96 $191 - $279	8	8 $0

124

49.6M

1.4K

2.3K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $566M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.